{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T07:06:15Z","timestamp":1778310375496,"version":"3.51.4"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2017,9,7]],"date-time":"2017-09-07T00:00:00Z","timestamp":1504742400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004396","name":"The Thailand Research Fund","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004396","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1007\/s00403-017-1777-5","type":"journal-article","created":{"date-parts":[[2017,9,7]],"date-time":"2017-09-07T07:17:23Z","timestamp":1504768643000},"page":"729-738","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Efficacy of topical tofacitinib in promoting hair growth in non-scarring alopecia: possible mechanism via VEGF induction"],"prefix":"10.1007","volume":"309","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7490-5134","authenticated-orcid":false,"given":"Jitlada","family":"Meephansan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Thummakriengkrai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Ponnikorn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Yingmema","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Deenonpoe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Suchonwanit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,9,7]]},"reference":[{"key":"1777_CR1","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1002\/dvdy.21151","volume":"236","author":"CA Ambler","year":"2007","unstructured":"Ambler CA, Watt FM (2007) Expression of Notch pathway genes in mammalian epidermis and modulation by \u03b2-Catenin. Dev Dyn 236:1595\u20131601","journal-title":"Dev Dyn"},{"key":"1777_CR2","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/S0140-6736(14)62113-9","volume":"386","author":"H Bachelez","year":"2015","unstructured":"Bachelez H, van de Kerkhof PCM, Strohal R, Kubanov A, Valenzuela F, Lee J-H, Yakusevich V, Chimenti S, Papacharalambous J, Proulx J, Gupta P, Tan H, Tawadrous M, Valdez H, Wolk R (2015) Tofacitinib versus etanercept or placebo in moderate-to-severe chronic plaque psoriasis: a phase 3 randomised non-inferiority trial. Lancet 386:552\u2013561","journal-title":"Lancet"},{"key":"1777_CR3","doi-asserted-by":"crossref","first-page":"389","DOI":"10.2332\/allergolint.10-OA-0207","volume":"59","author":"CJ Bae","year":"2010","unstructured":"Bae CJ, Shim SB, Jee SW, Lee SH, Kim MR, Lee JW, Lee CK, Hwang DY (2010) IL-6, VEGF, KC and RANTES are a major cause of a high irritant dermatitis to phthalic anhydride in C57BL\/6 inbred mice. Allergol Int 59:389\u2013397","journal-title":"Allergol Int"},{"key":"1777_CR4","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1038\/jid.2009.25","volume":"129","author":"MG Boy","year":"2009","unstructured":"Boy MG, Wang C, Wilkinson BE, Chow VF, Clucas AT, Krueger JG, Gaweco AS, Zwillich SH, Changelian PS, Chan G (2009) Double-blind, placebo-controlled, dose-escalation study to evaluate the pharmacologic effect of CP-690,550 in patients with psoriasis. J Invest Dermatol 129:2299\u20132302","journal-title":"J Invest Dermatol"},{"key":"1777_CR5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/PROM.S62879","volume":"14","author":"E Boyce","year":"2016","unstructured":"Boyce E, Vyas D, Rogan E, Valle-Oseguera C, O\u2019Dell K (2016) Impact of tofacitinib on patient outcomes in rheumatoid arthritis\u2014review of clinical studies. Patient Relat Outcome Meas 14:1","journal-title":"Patient Relat Outcome Meas"},{"key":"1777_CR6","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.2174\/1381612043384529","volume":"10","author":"M Cetkovic-Cvrlje","year":"2004","unstructured":"Cetkovic-Cvrlje M, Tibbles HE (2004) Therapeutic potential of Janus kinase 3 (JAK3) inhibitors. Curr Pharm Des 10:1767\u20131784","journal-title":"Curr Pharm Des"},{"key":"1777_CR7","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1002\/pros.22696","volume":"73","author":"RR Chhipa","year":"2013","unstructured":"Chhipa RR, Halim D, Cheng J, Zhang HY, Mohler JL, Ip C, Wu Y (2013) The direct inhibitory effect of dutasteride or finasteride on androgen receptor activity is cell line specific. Prostate 73:1483\u20131494","journal-title":"Prostate"},{"key":"1777_CR8","doi-asserted-by":"crossref","first-page":"2988","DOI":"10.1038\/jid.2014.260","volume":"134","author":"BG Craiglow","year":"2014","unstructured":"Craiglow BG, King BA (2014) Killing two birds with one stone: oral tofacitinib reverses alopecia universalis in a patient with plaque psoriasis. J Invest Dermatol 134:2988\u20132990","journal-title":"J Invest Dermatol"},{"key":"1777_CR9","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1001\/jamadermatol.2015.1520","volume":"151","author":"BG Craiglow","year":"2015","unstructured":"Craiglow BG, King BA (2015) Tofacitinib citrate for the treatment of vitiligo: a pathogenesis-directed therapy. JAMA Dermatol 151:1110\u20131112","journal-title":"JAMA Dermatol"},{"key":"1777_CR10","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1001\/jamadermatol.2015.4445","volume":"152","author":"BG Craiglow","year":"2016","unstructured":"Craiglow BG, Tavares D, King BA (2016) Topical Ruxolitinib for the Treatment of Alopecia Universalis. JAMA Dermatol 152:490","journal-title":"JAMA Dermatol"},{"key":"1777_CR11","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1111\/j.1743-6109.2008.01001.x","volume":"5","author":"F Erdemir","year":"2008","unstructured":"Erdemir F, Harbin A, Hellstrom WJG (2008) 5-alpha reductase inhibitors and erectile dysfunction: the connection. J Sex Med 5:2917\u20132924","journal-title":"J Sex Med"},{"key":"1777_CR12","first-page":"155","volume":"21","author":"G Faghihi","year":"2013","unstructured":"Faghihi G, Iraji F, Rajaee Harandi M, Nilforoushzadeh M-A, Askari G (2013) Comparison of the efficacy of topical minoxidil 5% and adenosine 0.75% solutions on male androgenetic alopecia and measuring patient satisfaction rate. Acta Dermatovenerol Croat 21:155\u2013159","journal-title":"Acta Dermatovenerol Croat"},{"key":"1777_CR13","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1056\/NEJMoa1109071","volume":"367","author":"R Fleischmann","year":"2012","unstructured":"Fleischmann R, Kremer J, Cush J, Schulze-Koops H, Connell CA, Bradley JD, Gruben D, Wallenstein GV, Zwillich SH, Kanik KS (2012) Placebo-controlled trial of tofacitinib monotherapy in rheumatoid arthritis. N Engl J Med 367:495\u2013507","journal-title":"N Engl J Med"},{"key":"1777_CR14","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1006\/dbio.1999.9325","volume":"212","author":"K Foitzik","year":"1999","unstructured":"Foitzik K, Paus R, Doetschman T, Dotto GP (1999) The TGF-beta2 isoform is both a required and sufficient inducer of murine hair follicle morphogenesis. Dev Biol 212:278\u2013289","journal-title":"Dev Biol"},{"key":"1777_CR15","doi-asserted-by":"crossref","first-page":"4234","DOI":"10.4049\/jimmunol.1003668","volume":"186","author":"K Ghoreschi","year":"2011","unstructured":"Ghoreschi K, Jesson MI, Li X, Lee JL, Ghosh S, Alsup JW, Warner JD, Tanaka M, Steward-Tharp SM, Gadina M, Thomas CJ, Minnerly JC, Storer CE, LaBranche TP, Radi ZA, Dowty ME, Head RD, Meyer DM, Kishore N, O\u2019Shea JJ (2011) Modulation of innate and adaptive immune responses by tofacitinib (CP-690,550). J Immunol 186:4234\u20134243","journal-title":"J Immunol"},{"key":"1777_CR16","first-page":"185","volume":"13","author":"AK Gupta","year":"2015","unstructured":"Gupta AK, Charrette A (2015) Topical minoxidil: systematic review and meta-analysis of its efficacy in androgenetic alopecia. Skinmed 13:185\u2013189","journal-title":"Skinmed"},{"key":"1777_CR17","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1111\/jdv.13598","volume":"30","author":"AK Gupta","year":"2016","unstructured":"Gupta AK, Carviel JL, Abramovits W (2016) Efficacy of tofacitinib in treatment of alopecia universalis in two patients. J Eur Acad Dermatol Venereol 30:1373\u20131378","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1777_CR18","doi-asserted-by":"crossref","first-page":"e1500973","DOI":"10.1126\/sciadv.1500973","volume":"1","author":"S Harel","year":"2015","unstructured":"Harel S, Higgins CA, Cerise JE, Dai Z, Chen JC, Clynes R, Christiano AM (2015) Pharmacologic inhibition of JAK-STAT signaling promotes hair growth. Sci Adv 1:e1500973","journal-title":"Sci Adv"},{"key":"1777_CR19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jdermsci.2010.10.015","volume":"61","author":"S Inui","year":"2011","unstructured":"Inui S, Itami S (2011) Molecular basis of androgenetic alopecia: from androgen to paracrine mediators through dermal papilla. J Dermatol Sci 61:1\u20136","journal-title":"J Dermatol Sci"},{"key":"1777_CR20","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/exd.13060","volume":"25","author":"A Jabbari","year":"2016","unstructured":"Jabbari A, Nguyen N, Cerise JE, Ulerio G, de Jong A, Clynes R, Christiano AM, Mackay-Wiggan J (2016) Treatment of an alopecia areata patient with tofacitinib results in regrowth of hair and changes in serum and skin biomarkers. Exp Derm 25:642\u2013643","journal-title":"Exp Derm"},{"key":"1777_CR21","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1111\/j.1365-4362.1993.tb02755.x","volume":"32","author":"JP Jacobs","year":"1993","unstructured":"Jacobs JP, Szpunar CA, Warner ML (1993) Use of topical minoxidil therapy for androgenetic alopecia in women. Int J Dermatol 32:758\u2013762","journal-title":"Int J Dermatol"},{"key":"1777_CR22","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1034\/j.1600-0625.2003.00089.x","volume":"12","author":"H Kamp","year":"2003","unstructured":"Kamp H, Geilen CC, Sommer C, Blume-Peytavi U (2003) Regulation of PDGF and PDGF receptor in cultured dermal papilla cells and follicular keratinocytes of the human hair follicle. Exp Derm 12:662\u2013672","journal-title":"Exp Derm"},{"key":"1777_CR23","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/S0190-9622(98)70007-6","volume":"39","author":"KD Kaufman","year":"1998","unstructured":"Kaufman KD, Olsen EA, Whiting D, Savin R, DeVillez R, Bergfeld W, Price VH, Van Neste D, Roberts JL, Hordinsky M, Shapiro J, Binkowitz B, Gormley GJ (1998) Finasteride in the treatment of men with androgenetic alopecia. Finasteride Male Pattern Hair Loss Study Group. J Am Acad Dermatol 39:578\u2013589","journal-title":"J Am Acad Dermatol"},{"key":"1777_CR24","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1111\/j.0022-202X.2005.23693.x","volume":"124","author":"M Kawano","year":"2005","unstructured":"Kawano M, Komi-Kuramochi A, Asada M, Suzuki M, Oki J, Jiang J, Imamura T (2005) Comprehensive analysis of FGF and FGFR expression in skin: FGF18 is highly expressed in hair follicles and capable of inducing anagen from telogen stage hair follicles. J Invest Dermatol 124:877\u2013885","journal-title":"J Invest Dermatol"},{"key":"1777_CR25","doi-asserted-by":"crossref","first-page":"136","DOI":"10.3746\/pnf.2014.19.3.136","volume":"19","author":"EJ Kim","year":"2014","unstructured":"Kim EJ, Choi JY, Park BC, Lee B-H (2014) Platycarya strobilacea S. et Z. Extract has a high antioxidant capacity and exhibits hair growth-promoting effects in male C57BL\/6 Mice. Prev Nutr Food Sci 19:136\u2013144","journal-title":"Prev Nutr Food Sci"},{"key":"1777_CR26","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1101\/gad.10.11.1382","volume":"10","author":"K Kratochwil","year":"1996","unstructured":"Kratochwil K, Dull M, Farinas I, Galceran J, Grosschedl R (1996) Lef1 expression is activated by BMP-4 and regulates inductive tissue interactions in tooth and hair development. Genes Dev 10:1382\u20131394","journal-title":"Genes Dev"},{"key":"1777_CR27","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1159\/000441622","volume":"1","author":"M Placa La","year":"2015","unstructured":"La Placa M, Balestri R, Bardazzi F, Vincenzi C (2015) Scalp Psoriasiform contact dermatitis with acute telogen effluvium due to topical minoxidil treatment. Skin Appendage Disord 1:141\u2013143","journal-title":"Skin Appendage Disord"},{"key":"1777_CR28","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/1523-1747.ep12326964","volume":"106","author":"S Lachgar","year":"1996","unstructured":"Lachgar S, Moukadiri H, Jonca F, Charveron M, Bouhaddioui N, Gall Y, Bonafe JL, Plou\u00ebt J (1996) Vascular endothelial growth factor is an autocrine growth factor for hair dermal papilla cells. J Invest Dermatol 106:17\u201323","journal-title":"J Invest Dermatol"},{"key":"1777_CR29","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/j.1346-8138.1999.tb03518.x","volume":"26","author":"LF Li","year":"1999","unstructured":"Li LF, Fiedler VC, Kumar R (1999) The potential role of skin protein kinase C isoforms alpha and delta in mouse hair growth induced by diphencyprone-allergic contact dermatitis. J Dermatol 26:98\u2013105","journal-title":"J Dermatol"},{"key":"1777_CR30","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1046\/j.1365-2230.2003.01328.x","volume":"28","author":"LF Li","year":"2003","unstructured":"Li LF, Guo J, Gao ZF (2003) Overexpression of skin protein kinase C-alpha in anagen hair follicles during induced growth of mouse hair. Clin Exp Dermatol 28:429\u2013433","journal-title":"Clin Exp Dermatol"},{"key":"1777_CR31","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1016\/j.ophtha.2012.01.028","volume":"119","author":"SH Liew","year":"2012","unstructured":"Liew SH, Nichols KK, Klamerus KJ, Li JZ, Zhang M, Foulks GN (2012) Tofacitinib (CP-690,550), a Janus kinase inhibitor for dry eye disease. Ophthalmol 119:1328\u20131335","journal-title":"Ophthalmol"},{"key":"1777_CR32","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.jaad.2003.06.014","volume":"50","author":"AW Lucky","year":"2004","unstructured":"Lucky AW, Piacquadio DJ, Ditre CM, Dunlap F, Kantor I, Pandya AG, Savin RC, Tharp MD (2004) A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss. J Am Acad Dermatol 50:541\u2013553","journal-title":"J Am Acad Dermatol"},{"key":"1777_CR33","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1046\/j.1365-4362.2000.00612.x","volume":"39","author":"YF Mah\u00e9","year":"2000","unstructured":"Mah\u00e9 YF, Michelet JF, Billoni N, Jarrousse F, Buan B, Commo S, Saint-L\u00e9ger D, Bernard BA (2000) Androgenetic alopecia and microinflammation. Int J Dermatol 39:576\u2013584","journal-title":"Int J Dermatol"},{"key":"1777_CR34","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1046\/j.0022-202x.2001.01570.x","volume":"117","author":"A Marubayashi","year":"2001","unstructured":"Marubayashi A, Nakaya Y, Fukui K, Li M, Arase S (2001) Minoxidil-induced hair growth is mediated by adenosine in cultured dermal papilla cells: possible involvement of sulfonylurea receptor 2B as a target of minoxidil. J Invest Dermatol 117:1594\u20131600","journal-title":"J Invest Dermatol"},{"key":"1777_CR35","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/j.1365-2133.2004.05785.x","volume":"150","author":"AG Messenger","year":"2004","unstructured":"Messenger AG, Rundegren J (2004) Minoxidil: mechanisms of action on hair growth. Br J Dermatol 150:186\u2013194","journal-title":"Br J Dermatol"},{"key":"1777_CR36","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/cei.12234","volume":"175","author":"K Migita","year":"2014","unstructured":"Migita K, Izumi Y, Jiuchi Y, Kozuru H, Kawahara C, Izumi M, Sakai T, Nakamura M, Motokawa S, Nakamura T, Kawakami A (2014) Effects of Janus kinase inhibitor tofacitinib on circulating serum amyloid A and interleukin-6 during treatment for rheumatoid arthritis. Clin Exp Immunol 175:208\u2013214","journal-title":"Clin Exp Immunol"},{"key":"1777_CR37","doi-asserted-by":"crossref","first-page":"ii111","DOI":"10.1136\/annrheumdis-2012-202576","volume":"72","author":"JJ O\u2019Shea","year":"2013","unstructured":"O\u2019Shea JJ, Kontzias A, Yamaoka K, Tanaka Y, Laurence A (2013) Janus kinase inhibitors in autoimmune diseases. Ann Rheum Dis 72:ii111\u2013ii115","journal-title":"Ann Rheum Dis"},{"key":"1777_CR38","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0190-9622(87)70179-0","volume":"17","author":"EA Olsen","year":"1987","unstructured":"Olsen EA, Weiner MS (1987) Topical minoxidil in male pattern baldness: effects of discontinuation of treatment. J Am Acad Dermatol 17:97\u2013101","journal-title":"J Am Acad Dermatol"},{"key":"1777_CR39","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.stem.2011.11.005","volume":"10","author":"N Oshimori","year":"2012","unstructured":"Oshimori N, Fuchs E (2012) Paracrine TGF-\u03b2 signaling counterbalances BMP-mediated repression in hair follicle stem cell activation. Cell Stem Cell 10:63\u201375","journal-title":"Cell Stem Cell"},{"key":"1777_CR40","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1254\/fpj.119.167","volume":"119","author":"S Otomo","year":"2002","unstructured":"Otomo S (2002) Hair growth effect of minoxidil. Nippon Yakurigaku Zasshi 119:167\u2013174","journal-title":"Nippon Yakurigaku Zasshi"},{"key":"1777_CR41","first-page":"804","volume":"28","author":"D Pathomvanich","year":"2002","unstructured":"Pathomvanich D, Pongratananukul S, Thienthaworn P, Manoshai S (2002) A random study of Asian male androgenetic alopecia in Bangkok, Thailand. Dermatol Surg 28:804\u2013807","journal-title":"Dermatol Surg"},{"key":"1777_CR42","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/1523-1747.ep12336635","volume":"109","author":"R Paus","year":"1997","unstructured":"Paus R, Foitzik K, Welker P, Bulfone-Paus S, Eichm\u00fcller S (1997) Transforming growth factor-beta receptor type I and type II expression during murine hair follicle development and cycling. J Invest Dermatol 109:518\u2013526","journal-title":"J Invest Dermatol"},{"key":"1777_CR43","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/ics.12341","volume":"38","author":"PM Ramos","year":"2016","unstructured":"Ramos PM, Brianezi G, Martins ACP, da Silva MG, Marques MEA, Miot HA (2016) Apoptosis in follicles of individuals with female pattern hair loss is associated with perifollicular microinflammation. Int J Cosmet Sci 38:651\u2013654","journal-title":"Int J Cosmet Sci"},{"key":"1777_CR44","doi-asserted-by":"crossref","first-page":"e331","DOI":"10.1371\/journal.pbio.0030331","volume":"3","author":"M Rendl","year":"2005","unstructured":"Rendl M, Lewis L, Fuchs E (2005) Molecular dissection of mesenchymal-epithelial interactions in the hair follicle. PLoS Biol 3:e331","journal-title":"PLoS Biol"},{"key":"1777_CR45","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1101\/gad.1614408","volume":"22","author":"M Rendl","year":"2008","unstructured":"Rendl M, Polak L, Fuchs E (2008) BMP signaling in dermal papilla cells is required for their hair follicle-inductive properties. Genes Dev 22:543\u2013557","journal-title":"Genes Dev"},{"key":"1777_CR46","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.exer.2015.12.005","volume":"145","author":"T Sakimoto","year":"2016","unstructured":"Sakimoto T, Ishimori A (2016) Anti-inflammatory effect of topical administration of tofacitinib on corneal inflammation. Exp Eye Res 145:110\u2013117","journal-title":"Exp Eye Res"},{"key":"1777_CR47","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1056\/NEJMoa1112168","volume":"367","author":"WJ Sandborn","year":"2012","unstructured":"Sandborn WJ, Ghosh S, Panes J, Vranic I, Su C, Rousell S, Niezychowski W (2012) Tofacitinib, an oral Janus kinase inhibitor, in active ulcerative colitis. N Engl J Med 367:616\u2013624","journal-title":"N Engl J Med"},{"key":"1777_CR48","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1056\/NEJMoa030660","volume":"349","author":"IM Thompson","year":"2003","unstructured":"Thompson IM, Goodman PJ, Tangen CM, Lucia MS, Miller GJ, Ford LG, Lieber MM, Cespedes RD, Atkins JN, Lippman SM, Carlin SM, Ryan A, Szczepanek CM, Crowley JJ, Coltman CA Jr (2003) The influence of finasteride on the development of prostate cancer. N Engl J Med 349:215\u2013224","journal-title":"N Engl J Med"},{"key":"1777_CR49","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1111\/j.1600-6143.2008.02307.x","volume":"8","author":"E Gurp van","year":"2008","unstructured":"van Gurp E, Weimar W, Gaston R, Brennan D, Mendez R, Pirsch J, Swan S, Pescovitz MD, Ni G, Wang C, Krishnaswami S, Chow V, Chan G (2008) Phase 1 Dose-Escalation Study of CP-690 550 in stable renal allograft recipients: preliminary findings of safety, tolerability, effects on lymphocyte subsets and pharmacokinetics. Am J Transplant 8:1711\u20131718","journal-title":"Am J Transplant"},{"key":"1777_CR50","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/nm.3645","volume":"20","author":"L Xing","year":"2014","unstructured":"Xing L, Dai Z, Jabbari A, Cerise JE, Higgins CA, Gong W, de Jong A, Harel S, DeStefano GM, Rothman L, Singh P, Petukhova L, Mackay-Wiggan J, Christiano AM, Clynes R (2014) Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition. Nat Med 20:1043\u20131049","journal-title":"Nat Med"},{"key":"1777_CR51","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1101\/gad.9.6.700","volume":"9","author":"P Zhou","year":"1995","unstructured":"Zhou P, Byrne C, Jacobs J, Fuchs E (1995) Lymphoid enhancer factor 1 directs hair follicle patterning and epithelial cell fate. Gen Dev 9:700\u2013713","journal-title":"Gen Dev"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00403-017-1777-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-017-1777-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-017-1777-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,10,19]],"date-time":"2017-10-19T07:16:36Z","timestamp":1508397396000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00403-017-1777-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,7]]},"references-count":51,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["1777"],"URL":"https:\/\/doi.org\/10.1007\/s00403-017-1777-5","relation":{},"ISSN":["0340-3696","1432-069X"],"issn-type":[{"value":"0340-3696","type":"print"},{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,7]]}}}